Kairos Pharma, Ltd. (KAPA)
Official siteHEALTHCARE • BIOTECHNOLOGY • AMEX
Market Cap: $1.54M
Last updated: Nov 17, 2026 at 11:03 AM ET
Kairos Pharma, Ltd. (KAPA) Competitors
The companies most similar to Kairos Pharma are Calidi Biotherapeutics (CLDI), PharmaCyte Biotech (PMCB) and Scinai Immunotherapeutics (SCNI). By market cap, Kairos Pharma ranks 12th of the 13 companies on this page; Liminatus Pharma, Inc. Class A Common Stock (LIMN) is the largest at $4.02M.
Peer Comparison
KAPA's revenue growth of 0.0% is in line with the peer median. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| Kairos Pharma (KAPA) | $1.54M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Calidi Biotherapeutics Inc. (CLDI) | $2.29M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| PharmaCyte Biotech Inc (PMCB) | $3.77M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Scinai Immunotherapeutics Ltd (SCNI) | $1.05M | N/A | N/A | -80.1% | N/A | 572.0% | 0.00% |
| Curis Inc (CRIS) | $2.97M | N/A | 1.6x | 0.0% | N/A | -66.0% | 0.00% |
| Purple Biotech (PPBT) | $2.65M | N/A | N/A | 0.0% | -156.2% | 0.0% | 0.00% |
| Enlivex Therapeutics Ltd (ENLV) | $1.82M | N/A | N/A | 0.0% | -0.3% | 0.0% | 0.00% |
| Ernexa Therapeutics Inc. (ERNA) | $2.84M | N/A | N/A | 0.0% | N/A | -94.1% | 0.00% |
| XORTX Therapeutics Inc (XRTX) | $2.00M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Genprex Inc (GNPX) | $1.71M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Revelation Biosciences Inc (REVB) | $2.43M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| 60 Degrees Pharmaceuticals, Inc. Common Stock (SXTP) | $1.82M | N/A | 1.7x | 0.0% | N/A | -32.5% | 0.00% |
| Liminatus Pharma, Inc. Class A Common Stock (LIMN) | $4.02M | N/A | N/A | 0.0% | -247.2% | 0.0% | 0.00% |
| Peer median | $2.36M | N/A | 1.7x | 0.0% | -156.2% | 0.0% | 0.00% |
Similar Companies
These are the 12 companies most similar to Kairos Pharma, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.
| Company | About | Peers |
|---|---|---|
| Calidi Biotherapeutics Inc. (CLDI) | Calidi Biotherapeutics, Inc., a clinical stage immuno-oncology company, engages in developing immunotherapies for the treatment of cancer. | CLDI competitors |
| PharmaCyte Biotech Inc (PMCB) | PharmaCyte Biotech, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cell therapies for cancer and diabetes in the United... | PMCB competitors |
| Scinai Immunotherapeutics Ltd (SCNI) | Scinai Immunotherapeutics Ltd is an innovative biotechnology company focused on developing cutting-edge immunotherapy solutions for cancer and autoimmune... | SCNI competitors |
| Curis Inc (CRIS) | Curis, Inc., a biotechnology company, is dedicated to the discovery and development of drug candidates for the treatment of human cancers in the United States. | CRIS competitors |
| Purple Biotech (PPBT) | Purple Biotech Ltd., a clinical-stage pharmaceutical company, focuses on the development and commercialization of various pharmaceutical drugs in the United... | PPBT competitors |
| Enlivex Therapeutics Ltd (ENLV) | Enlivex Therapeutics Ltd. is a clinical stage immunotherapy company. The company is headquartered in Nes Ziona, Israel. | ENLV competitors |
| Ernexa Therapeutics Inc. (ERNA) | Brooklyn ImmunoTherapeutics, Inc., a clinical-stage biopharmaceutical company, is dedicated to developing therapies to treat cancer patients. | ERNA competitors |
| XORTX Therapeutics Inc (XRTX) | XORTX Therapeutics Inc., a biopharmaceutical company, is dedicated to the development and commercialization of therapies to treat progressive kidney disease... | XRTX competitors |
| Genprex Inc (GNPX) | Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. | GNPX competitors |
| Revelation Biosciences Inc (REVB) | Revelation Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development of immunological diagnostics and therapeutics... | REVB competitors |
| 60 Degrees Pharmaceuticals, Inc. Common Stock (SXTP) | 60 Degrees Pharmaceuticals, Inc. is a specialty pharmaceutical company that engages in the development and commercialization of therapies for the prevention... | SXTP competitors |
| Liminatus Pharma, Inc. Class A Common Stock (LIMN) | Liminatus Pharma, Inc. is a clinical-stage immuno-oncology company that develops novel cancer therapies. The company is headquartered in LA Palma, California. | LIMN competitors |
Frequently Asked Questions About KAPA
Who are Kairos Pharma's main competitors?
The companies most similar to Kairos Pharma include Calidi Biotherapeutics (CLDI), PharmaCyte Biotech (PMCB), Scinai Immunotherapeutics (SCNI), Curis (CRIS) and Purple Biotech (PPBT), listed from the closest match.
Who is Kairos Pharma's biggest competitor?
Liminatus Pharma, Inc. Class A Common Stock (LIMN) is the largest of the similar companies at $4.02M; Calidi Biotherapeutics (CLDI) is the closest match by business profile, size, sector and industry.
How does KAPA stock compare with its competitors?
KAPA's net margin is 0.0% against a peer median of 0.0%.
Which of Kairos Pharma's competitors pays a higher dividend?
Kairos Pharma pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.
Is Kairos Pharma bigger than its competitors?
No. Kairos Pharma is 12th by market cap among the 13 companies on this page; the largest is Liminatus Pharma, Inc. Class A Common Stock (LIMN) at $4.02M.
KAPA pages: Overview, Earnings, Forecast, Financials, Competitors